LN-145
C-145-03
Phase 2 mab completed
Quick answer
LN-145 for Squamous Cell Carcinoma of the Head and Neck is a Phase 2 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Squamous Cell Carcinoma of the Head and Neck
- Phase
- Phase 2
- Modality
- mab
- Status
- completed